TADALAFIL TEVA 20 mg, film-coated tablet scored 8 tablets, CIP 3400930102480
Active ingredients: Tadalafil
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored8 tablets, CIP 3400930102480orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TADALAFIL TEVA 20 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé sécable
- Route of administration
- orale
- Presentation description
- 8 plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène PVC-Aluminium de 1 comprimé(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 3 Oct 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69709274CIP73010248CIP133400930102480Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TADALAFILcomprimé | 20 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
- 4 tablets, CIP 3400930293034Commercialized according to BDPM
- 8 tablets, CIP 3400930293041Commercialized according to BDPM
- 24 tablets, CIP 3400930293058Commercialized according to BDPM
- 4 tablets, CIP 3400930094631Commercialized according to BDPM
- 24 tablets, CIP 3400930094655Commercialized according to BDPM
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.